Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Share Price
Equities
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.81 CNY | -0.09% |
|
-0.09% | +48.73% |
| 26/11 | Tianjin Pharmaceutical Da Ren Tang Gets China Approval for Pain Relief Patch | MT |
| 25/11 | Tianjin Pharmaceutical Da Ren Tang's Unit Granted Registration Certificate by Chinese Authority | MT |
| Capitalization | 3.06TCr 432.74Cr 371.81Cr 348.82Cr 325.03Cr 598.57Cr 39TCr 650.5Cr 4.05TCr 1.57TCr 18TCr 1.62TCr 1.59TCr 68TCr | P/E ratio 2025 * |
15.2x | P/E ratio 2026 * | 31.4x |
|---|---|---|---|---|---|
| Enterprise value | 3.06TCr 432.74Cr 371.81Cr 348.82Cr 325.03Cr 598.57Cr 39TCr 650.5Cr 4.05TCr 1.57TCr 18TCr 1.62TCr 1.59TCr 68TCr | EV / Sales 2025 * |
6.23x | EV / Sales 2026 * | 5.72x |
| Free-Float |
31.72% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
More news
| 1 day | -0.09% | ||
| 1 week | -0.09% | ||
| Current month | +0.73% | ||
| 1 month | -6.70% | ||
| 3 months | -1.27% | ||
| 6 months | +32.21% | ||
| Current year | +48.73% |
| 1 week | 45.7 |  | 46.76 |
| 1 month | 44.8 | | 50.95 |
| Current year | 28.53 | | 50.97 |
| 1 year | 28.53 | | 50.97 |
| 3 years | 23.4 | | 56.26 |
| 5 years | 16.58 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Ma
DFI | Director of Finance/CFO | 47 | 21/07/2023 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 55 | 10/10/2017 |
Jian Wang
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Lei Wang
CHM | Chairman | 54 | 26/11/2024 |
Hong Zhou
BRD | Director/Board Member | 55 | 01/12/2012 |
Yoke Pheng Liew
BRD | Director/Board Member | 69 | 05/06/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | -0.09% | +44.83% | +52.85% | 432.7Cr | |
| -0.63% | -1.87% | -17.87% | -32.51% | 644.4Cr | |
| -1.36% | -0.13% | -17.89% | +22.74% | 434.99Cr | |
| -2.12% | -6.79% | +3.23% | -66.05% | 424.16Cr | |
| +0.66% | +0.26% | -7.81% | -10.60% | 354.66Cr | |
| -0.52% | -1.81% | +5.27% | +29.06% | 322.66Cr | |
| -1.72% | -2.24% | -2.36% | -36.45% | 251.63Cr | |
| -1.30% | -2.40% | +8.21% | -1.97% | 198.94Cr | |
| -0.46% | -0.27% | +1.11% | +58.02% | 175Cr | |
| +1.33% | +1.10% | +3.56% | +56.03% | 168.94Cr | |
| Average | -0.62% | -1.74% | +2.03% | +7.11% | 340.81Cr | |
| Weighted average by Cap. | -0.71% | -1.97% | +0.66% | -0.16% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 490.8Cr 69Cr 60Cr 56Cr 52Cr 96Cr 6.24TCr 104.45Cr 649.53Cr 252.45Cr 2.96TCr 260.75Cr 255.23Cr 11TCr | 534.8Cr 76Cr 65Cr 61Cr 57Cr 104.73Cr 6.8TCr 113.82Cr 707.76Cr 275.08Cr 3.22TCr 284.13Cr 278.11Cr 12TCr |
| Net income | 232.5Cr 33Cr 28Cr 27Cr 25Cr 46Cr 2.96TCr 49Cr 307.69Cr 119.59Cr 1.4TCr 123.52Cr 120.91Cr 5.17TCr | 112.4Cr 16Cr 14Cr 13Cr 12Cr 22Cr 1.43TCr 24Cr 148.75Cr 58Cr 677.7Cr 60Cr 58Cr 2.5TCr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
4,619
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/25/09 | 45.81 ¥ | -0.09% | 35,72,148 |
| 08/25/08 | 45.85 ¥ | -1.38% | 50,87,845 |
| 05/25/05 | 46.49 ¥ | +0.26% | 29,92,804 |
| 04/25/04 | 46.37 ¥ | +0.13% | 27,89,421 |
| 03/25/03 | 46.31 ¥ | +1.00% | 37,68,780 |
End-of-day quote Shanghai S.E., December 09, 2025
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
45.81
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition